worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Investor Relations

Novartis Investor Relations

Financial results 

Find annual, quarterly and product sales and results.

Share data and analysis 

Learn about Novartis share performance.

Event calendar 

Company information 

Read about Novartis leaders, acquisitions and more.

Fixed-income securities 

Learn about the fixed-income securities issued by Novartis.

Shareholder information 

Find out about our purchase plans, Annual General Meeting, and more.

 

USD 24.5 million 
Projects submitted to the 2009 Novartis Energy Excellence Awards are expected to save USD 24.5 million.

USD 7.5 billion 
During 2009, Novartis invested USD 7.5 billion in research and development. This is one of the highest figures in the industry relative to sales (17 percent).

SIX

NYSE

 
 
 
 

Alcon

Alcon

Novartis completes 77% majority ownership of Alcon adding new growth platform in eye care to its leading healthcare portfolio.

Corporate publications

Corporate publications

Download our latest financial reports.